Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04563559Phase 3Withdrawn
Phase 3, randomised, open-label trial of dexamethasone iontophoretic patch in post-operative inflammation and postoperative pain, sponsored by Duke University. Primary endpoints: Percent of patients who stated they preferred dexamethasone insert and Percent of patients who stated they preferred topical prednisolone insert. Planned start Nov 2020; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04563559.